Concepedia

Publication | Open Access

Phase Ia/Ib Study of the Selective MET Inhibitor, Savolitinib, in Patients with Advanced Solid Tumors: 
Safety, Efficacy, and Biomarkers

14

Citations

8

References

2022

Year

Abstract

NCT0198555.

References

YearCitations

Page 1